RxDoctor Payments Data

Greg Hites

Family · Connellsville, PANPI 1104233907

Payments from drug & device makers

$6,559in general payments, 2019–2025

Across 267 payments — averaging $24.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Collegium Pharmaceutical, Inc.$1K
  • Medtronic$992
  • Nalu Medical, Inc.$603
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$435
  • Valinor Pharma, LLC$192
  • plus $1K from 18 others

What the payments were for

  • Travel & lodging$5538%
  • Food & beverage$6,00792%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,559 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$165,073
Medicare patients
229
Services billed
2,085

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate388$265,813
OxycontinOxycodone Hcl118$89,833
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,722$40,481
Oxymorphone Hcl ErOxymorphone Hcl59$36,749
MovantikNaloxegol Oxalate82$32,507
RelistorMethylnaltrexone Bromide13$32,327
NucyntaTapentadol Hcl13$24,121
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,149$21,443
SymproicNaldemedine Tosylate35$18,026
Morphine Sulfate ErMorphine Sulfate717$15,927
Buprenorphine44$15,752
Naloxone Hcl212$15,521
Fentanyl164$14,578
Diclofenac Sodium253$11,872
Gabapentin889$11,413

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta, Belbuca$1,292$297,416417 claims
Redhill Biopharma Inc.Movantik$49$32,50782 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$435$32,32713 claims
Scilex Pharmaceuticals Inc.Ztlido$161$10,56923 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,717 family providers in Pennsylvania.

Other family in Connellsville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →